Drug manufacturer Ranbaxy has recalled 41 lots of generic atorvastatin tablets due to the potential for contamination with small glass particles, according to an FDA press release.
The recall includes 10-mg, 20-mg and 40-mg oral doses of the medication, sold in 90 and 500 tablet increments, and labeled with expiration dates of July 31, 2014 and Aug. 31, 2014. The 80-mg dosage form is not included in the recall.
Health care providers and patients can identify the white colored tablets by the imprint RX12 on 10-mg tablets, RX828 on 20-mg tablets and RX829 on 40-mg tablets, the FDA said.
Continue Reading
So far there have been no reports of adverse events associated with the medication, and the recall was initiated as a precaution. The glass particles are about 1 mm in size and resemble fine grains of sand.
“Because of the size of the particles which may be present in the affected lots it is unlikely to cause a significant safety concern. However, the possibility of adverse experiences arising primarily due to physical irritation cannot be ruled out,” Ranbaxy said in a statement.
A full list of the affected medication lots is available, here.
